Ethics Issues Remain Central to Genetic Engineering and Biotechnology – Genetic Engineering & Biotechnology...
By Thomas H. Murray, PhD
In 1982, when I wrote my first ethics column for Genetic Engineering News, enthusiasm for genetic engineering’s potential to remake medicine, manufacturing, and agriculture was set against grave concerns for...
Cancer patients on chemotherapy have lower immune response to COVID-19 vaccine, study finds
The COVID-19 pandemic has been an especially stressful time for cancer patients undergoing chemotherapy, which attacks not only the cancer, but also the immune cells needed to defend the body from infections. New research...
India, Colombia exchange views on cooperation in biotechnology sector – Economic Times
India and Colombia exchanged views on possible scientific cooperation in the biotechnology sector as the latter showed willingness for a tie-up in the areas of vaccines, biosimilars and medical devices.
A high-level delegation from Colombia...
Lokeshwar honored for excellence in urologic research
AUGUSTA, Ga. (Oct. 1, 2021) – Dr. Vinata Lokeshwar, chair of the Department of Biochemistry and Molecular Biology at the Medical College of Georgia at Augusta University, is the recipient of the Society of Women...
Go Your Own Way: Vector Laboratories Completes $124 Million Buyout and Initiates Acquisition Strategy
The new funding, backed by private equity firm Thompson Street Capital Partners, enables Vector Laboratories to embark upon an acquisition strategy while accelerating the commercialization of innovative labeling and detection technologies for immunohistochemistry, immunofluorescence,...
Frontier instructor named Biotechnology Teacher of the Year – GazetteNET
Frontier instructor named Biotechnology Teacher of the Year
...
Merck to Seek FDA EUA for COVID-19 Pill after Positive Phase III Data
Merck CEO and president Robert M. Davis
Merck & Co., said today it will pursue FDA emergency use authorization (EUA) “as soon as possible” for molnupiravir, the COVID-19 oral antiviral candidate it is developing with...
Common Mutation in Gliomas Sensitizes Them to Immunotherapy
A common mutation in gliomas sensitizes them to immunotherapy, a finding that researchers believe could have broader therapeutic implications for all glioma patients, according to new mouse model findings (“G-CSF secreted by mutant IDH1...
Tyler Van Buren Joins Cowen’s Equity Research Team to Cover Biotechnology – Post Register
NEW YORK, Oct. 01, 2021 (GLOBE NEWSWIRE) -- Cowen Inc. (NASDAQ:COWN) (“Cowen” or the “Company”) today announced that Tyler Van Buren has joined the Company’s equity research team to further expand the firm’s...
New defense mechanism makes lethal Salmonella strain resistant to viral infection
Scientists at the University of Liverpool and Harvard Medical School have discovered a new defense mechanism that makes a lethal strain of Salmonella resistant to viral infection. The findings, published in Cell Host &...
